HomeNews

News

Survivor’s Guilt: Asking, ‘Why Me?’

Regardless of being declared cancer-free after preliminary remedy, I grapple with survivor's guilt, questioning why my lymphoma responded to remedy whereas others didn't.

Most cancers Therapies Authorized by the FDA in December 2024

The Meals and Drug Administration in December permitted a number of new most cancers medication, together with remedies for lung, pancreatic and pores...

A Dedication to New Therapies for MPN Regardless of Scientific Challenges

A researcher mentioned the evolving understanding of myeloproliferative neoplasms (MPNs), from their preliminary classification to their potential for development, and emphasised the scientific...

GD2 CAR T Cells Present Promise In opposition to DMG

January 2, 2025, ...

Oncology Nurses Making a Distinction in Sufferers With Most cancers

Two oncology nurses nominated for the 2024 Extraordinary Healer Award spotlight the compassionate, patient-centered care that builds belief and improves the lives of...

Hot Topics